This site is intended for Healthcare Professionals only

Multiple choices: LloydsPharmacy working with Cancer Vanguard

Practice bookmark icon off

Multiple choices: LloydsPharmacy working with Cancer Vanguard

A partnership between the University of Manchester and Greater Manchester Cancer Vanguard Innovation has created an opportunity for patients to go to a community pharmacy to have their risk of having cancer assessed. 

LloydsPharmacy is working in collaboration with the partnership to support individuals in using a specially designed online tool that can help check for symptoms of cancer. Trained LloydsPharmacy pharmacists help participants complete a series of questions during a face-to-face consultation within the pharmacy. The service is currently being piloted exclusively in two LloydsPharmacy stores in Manchester.

The questionnaire, known as REACT (Risk Estimation for Additional Cancer Testing), has been designed to help identify symptoms that could indicate the presence of cancer. Participants are given an estimate of their risk of having cancer and individuals with high risk scores are referred to a GP for further investigations to help improve early diagnosis of the disease.

According to the Vanguard, Greater Manchester has a disproportionately high percentage of people whose cancer is detected only at later stages.

The REACT questionnaires are conducted in private consultation rooms, led by a specially trained pharmacist.

The project is led by Professor Ken Muir, Professor of Epidemiology at the University of Manchester, who said: “One of the ways we can improve rates of early diagnosis is by encouraging people to engage with the health services much sooner. We’re very excited by the potential of the questionnaire and this partnership allows us to bring it right into the heart of the community.”

 

Copy Link copy link button

Practice

Share: